Heinz-Otto Peitgen
Director/Board Member at Jacobs University Bremen
Heinz-Otto Peitgen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Jacobs University Bremen | Director/Board Member | 2012-12-31 | - |
| Zentrum für Kunst und Medientechnologie | Director/Board Member | 2001-12-31 | - |
| University of Bremen | Corporate Officer/Principal | 1976-12-31 | - |
| University of Graz | Director/Board Member | 2002-12-31 | - |
| Stiftung Bremer Wertpapierbörse | Director/Board Member | - | - |
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 2020-10-11 | - |
Career history of Heinz-Otto Peitgen
Former positions of Heinz-Otto Peitgen
| Companies | Position | Start | End |
|---|---|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Chairman | 2010-06-07 | - |
| Founder | 1996-12-31 | - |
Statistics
International
| Germany | 6 |
| Austria | 2 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 5 |
| Chairman | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MEVIS MEDICAL SOLUTIONS AG | Technology Services |
| Private companies | 3 |
|---|---|
| Zentrum für Kunst und Medientechnologie | |
| Stiftung Bremer Wertpapierbörse | |
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Brainomix Ltd. develops imaging biomarkers for neurological and cerebrovascular disorders. It offers e-ASPECTS, medical imaging software that automates a scoring system on brain images from acute ischaemic stroke patients to identify and quantify signs of early stroke damage and assist the physician's decision to treat. The company founded by Michalis Papadakis, Alastair Buchan, Iris Grunwald, Constantin Thiopoulos, and Michael Printzos in 2010 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Heinz-Otto Peitgen
- Experience
